Möchten Sie immer auf dem neuesten Stand bleiben?

GAITHERSBURG, Md., April 08, 2026 (GLOBE NEWSWIRE) -- Remedy Plan Therapeutics, a clinical-stage biotechnology company developing novel therapies that target fundamental metabolic vulnerabilities in...

Dublin, April 08, 2026 (GLOBE NEWSWIRE) -- The "Pharmacogenomics Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The Pharmacogenomics Market is...

Enrolling Phase 2 DAYBreak CLL-201 bexobrutideg trial designed to support Accelerated Approval in relapsed/refractory chronic lymphocytic leukemia (r/r CLL) Enabling Phase 3 DAYBreak CLL-306...

LOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including...

— Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval —  RESEARCH TRIANGLE PARK, N.C., April 06, 2026 (GLOBE NEWSWIRE) --...

The falling sensor costs and edge analytics are accelerating IoT adoption across hospitals and home‑care healthcare settings globally.

PARIS, FRANCE, 3 April 2026 — Ipsen (Euronext: IPN; ADR: IPSEY) announces that Beech Tree — which directly and indirectly holds 26.03% of Ipsen S.A.’s share capital and 33.05% of its voting rights —...

2025 financial highlights: Cash and cash equivalents totaled €101.1 million as of December 31, 2025Revenues amounting to €65.4 million for the period ended December 31, 2025, including €43.6 million...

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Tumor Microenvironment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The tumor microenvironment (TME) market has...

KNOXVILLE, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today highlighted newly published independent preclinical...